A study of immunohistochemical differential expression in pulmonary and mammary carcinomas

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Modern Pathology

• Publication date

  2010-02-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/modpathol.2010.38PMID 20173733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GCDFP-15 Positive and TTF-1 Negative Primary Lung Neoplasms: A Tissue Microarray Study of 381 Primary Lung Tumors

  2009cited by this paper
• The significance of GATA3 expression in breast cancer: a 10-year follow-up study.

  2009cited by this paper
• GATA-3 and the regulation of the mammary luminal cell fate.

  2008cited by this paper
• Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors.

  2008cited by this paper
• Gross Cystic Disease Fluid Protein—(GCDFP-15): Expression in Primary Lung Adenocarcinoma

  2008cited by this paper
• Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.

  2007cited by this paper
• Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers

  2007cited by this paper
• Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.

  2007cited by this paper
• Immunohistochemical Expression of Estrogen Receptor in Pulmonary Adenocarcinoma

  2006cited by this paper
• Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.

  2005cited by this paper
• Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs.

  2005cited by this paper
• Primary Mucinous (So-called Colloid) Carcinomas of the Lung: A Clinicopathologic and Immunohistochemical Study With Special Reference to CDX-2 Homeobox Gene and MUC2 Expression

  2004cited by this paper
• Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

  2003cited by this paper
• Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors

  2003cited by this paper
• 多彩な組織像を呈した乳腺Carcinoma with metaplasiaの一例

  2003cited by this paper
• Involvement of Napsin A in the C- and N-terminal Processing of Surfactant Protein B in Type-II Pneumocytes of the Human Lung*

  2003cited by this paper
• Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma.

  2003cited by this paper
• Second cancers after breast cancer treatment.

  2003cited by this paper
• Relationship between mammaglobin expression and estrogen receptor status in breast tumors

  2003cited by this paper
• The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy

  2003cited by this paper
• Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases

  2002cited by this paper
• Lung cancer risks in women with previous breast cancer.

  2002cited by this paper
• Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma.

  2002cited by this paper
• Estrogen and progesterone receptors in non small cell lung cancer patients.

  2002cited by this paper
• TTF-1 Expression in Pulmonary Adenocarcinomas

  2002cited by this paper
• Rosen's Breast Pathology, 2nd ed.

  2002cited by this paper
• Second Primary Cancers Following Breast Cancer in the Japanese Female Population

  2001cited by this paper
• Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.

  2001cited by this paper
• Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung

  2001cited by this paper
• Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection.

  2000cited by this paper
• Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B

  2000cited by this paper
• Regulation of surfactant protein gene transcription.

  1998cited by this paper
• Thyroid Transcription Factor-1 and Cytokeratins 7 and 20 in Pulmonary and Breast Carcinoma

  1998cited by this paper
• Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.

  1998cited by this paper
• Incidence of second primary cancers in three Italian population-based cancer registries.

  1997cited by this paper
• Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.

  1997cited by this paper
• Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites

  1996cited by this paper
• Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.

  1996cited by this paper
• Coordinate expression of cytokeratin 7 and 20 defines unique subsets of carcinomas

  1995cited by this paper
• Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung.

  1994cited by this paper
• Pulmonary resection for metastatic breast cancer.

  1994cited by this paper
• Sex hormone receptors in non-small-cell lung cancer in human beings.

  1994cited by this paper
• Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung.

  1994cited by this paper
• Adenocarcinoma in the lung in patients with breast cancer. A prospective analysis of the discriminatory value of immunohistology.

  1993cited by this paper
• Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast.

  1993cited by this paper
• Cerebral metastases as first symptom of bronchogenic carcinoma. A prospective study of 37 cases

  1991cited by this paper
• Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.

  1989cited by this paper
• Metastatic metaplastic carcinoma of the breast: Diagnosis by bronchial brush cytology

  1989cited by this paper
• Metastatic pattern in recurrent breast cancer: Special reference to intrathoracic recurrences

  1988cited by this paper
• Chloroquine-induced cardiomyopathy.

  1988cited by this paper
• Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors: Special reference to nonmucus producing lung adenocarcinomas

  1988cited by this paper
• The solitary pulmonary nodule in the patient with breast cancer.

  1984cited by this paper
• Central nervous system metastasis from breast carcinoma autopsy study

  1983cited by this paper
• Bronchogenic carcinoma in breast carcinoma patients.

  1983cited by this paper
• Mucoepidermoid and squamous cell carcinomas of breast with reference to squamous metaplasia and giant cell tumors

  1983cited by this paper
• Breast carcinoma: Pattern of metastasis at autopsy

  1983cited by this paper
• Breast cancer and thoracic metastases: review of 119 patients.

  1983cited by this paper
• [Secondary malignancies after breast cancer surgery. Comparison of retro- and prospective findings].

  1982cited by this paper
• Endobronchial metastatic disease.

  1982cited by this paper
• Metastases from carcinoma of mammary gland: An autopsy study

  1979cited by this paper
• The spread of breast cancer: importance of the intrathoracic lymphatic route and its relevance to treatment.

  1979cited by this paper
• Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up.

  1977cited by this paper
• Significance of a Solitary Lung Shadow in Patients With Breastd Cancer

  1975cited by this paper
• Tumours of the lung.

  1974cited by this paper
• Metaplastic breast carcinoma. Rare form of mammary cancer.

  1973cited by this paper
• Metaplastic breast carcinoma. Rare form of mammary cancer.

  1973cited by this paper
• Thoracotomy on the patient with previous malignancy: metastasis or new primary?

  1968cited by this paper
• Tumours of the Breast

  1962cited by this paper
• Metastases in carcinoma. Analysis of 1000 autopsied cases

  1950cited by this paper
• Tumours of the lung

  1938cited by this paper
• Tumours of the Breast

  1894cited by this paper

• A Practical Approach to the Diagnosis of Liver Metastases from Cancer of Unknown Primary: Application of Immunohistochemistry and an Update.

  2025cites this paper
• Dextroposition of the Heart From Tension Hydrothorax in a Patient With Malignant Pleural Effusion

  2025cites this paper
• The Role of Pulmonary Collectins, Surfactant Protein A (SP-A) and Surfactant Protein D (SP-D) in Cancer

  2024cites this paper
• GATA3 Expression in Primary Lung Carcinomas: Correlation with Histopathologic Features and TTF-1, Napsin A, and p40 Expression.

  2023cites this paper
• GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors

  2023cites this paper
• Metastatic Tumors of Unknown Primary (Muos) Definition, Frequency and General Considerations

  2023cites this paper
• Immunohistochemistry comparison of Napsin A and CK7 expression in primary lung adenocarcinoma

  2023cites this paper
• Evaluation of GATA3 and GCDFP15 Expression in Triple Negative Breast Cancers

  2023cites this paper
• Immunohistochemical study of proline, glutamic acid and leucine-rich protein 1 (PELP1) in correlation with guanine adenine thymine adenine family member 3 (GATA-3) receptors expression in breast carcinomas

  2023cites this paper
• A case of BRCA2-pathogenic variant breast cancer with metachronous endometrial cancer and pancreatic cancer: Case report and review of literature

  2023cites this paper
• A comprehensive analysis of GATA3 expression in carcinomas of various origins with emphasis on lung carcinomas.

  2023cites this paper
• A Case of BRCA2-Pathogenic Variant Breast Cancer With Metachronous Endometrial Cancer and Pancreatic Cancer

  2023cites this paper
• Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin

  2022cites this paper
• Intraoperative rapid immunohistochemistry with noncontact antibody mixing for undiagnosed pulmonary tumors

  2022cites this paper
• Value of Proline, Glutamic Acid, and Leucine-Rich Protein 1 and GATA Binding Protein 3 Expression in Breast Cancer: An Immunohistochemical study

  2022cites this paper
• Diagnostic utility of PELP1 and GATA3 in primary and metastatic triple negative breast cancer

  2022cites this paper
• Avoiding “False Positive” and “False Negative” Immunohistochemical Results in Breast Pathology

  2022cites this paper
• Diagnostic Approach According to More Frequent Metastatic Sites: Liver, Lung, Bone, and Lymph Nodes

  2022cites this paper
• Surgical Cases of Pulmonary Nodules in Patients with Breast Cancer

  2021cites this paper
• Cancer of Unknown Primary: Challenges and Progress in Clinical Management

  2021cites this paper
• Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer

  2021cites this paper
• GATA binding protein 3 (GATA3) as a marker for metaplastic spindle cell carcinoma of the breast.

  2021cites this paper
• A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa

  2021cites this paper
• Metastatic adenocarcinoma to the breast from the lung simulates primary breast carcinoma—a clinicopathologic study

  2021cites this paper
• Breast carcinoma metastasising to the gastric wall and the peritoneum: what physicians need to know

  2021cites this paper
• Lung Adenocarcinoma Metastatic to the Cervix: Report of a Rare Case and Review of the Literature

  2021cites this paper
• Methionyl-tRNA synthetase and aminoacyl-tRNA synthetases interacting multi-functional protein-lacking exon 2 as potential diagnostic biomarkers for lung cancer.

  2021cites this paper
• Squamous cell carcinoma of uterine cervix metastatic to the axillary lymph node

  2021cites this paper
• Prevalence of GATA-3 in invasive breast cancer and its significance in predicting response to neoadjuvant chemotherapy: a tertiary center experience

  2021cites this paper
• Evaluation of the Diagnostic Role of Gata3 Immunohistochemistry on Cytology Specimens for Metastatic Breast Carcinoma

  2021cites this paper
• Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors

  2021cites this paper
• A Neural Network Framework for Predicting the Tissue-of-Origin of 15 Common Cancer Types Based on RNA-Seq Data

  2020cites this paper
• Breast metastasis from EGFR/ALK negative lung adenocarcinoma

  2020cites this paper
• Malignant Epithelial Tumors of the Lung

  2020cites this paper
• A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin.

  2020cites this paper
• Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer.

  2020cites this paper
• Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases

  2020cites this paper
• Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies

  2020cites this paper
• THE MOST PROFOUND TRANSCRIPTIONAL FACTOR OF BREAST CANCER AND ITS CORRELATION WITH TRADITIONAL IMMUNOHISTOCHEMICAL RECEPTOR BIOMARKERS IN IRAQI WOMEN

  2020cites this paper
• An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin

  2020cites this paper
• Oncological Surgical Pathology

  2020cites this paper
• Immunohistochemistry for diagnosis and prognosis of breast cancer: a review

  2020cites this paper
• Practical Application of Lineage-Specific Immunohistochemistry Markers: Transcription Factors (Sometimes) Behaving Badly.

  2020cites this paper
• Incidence and natural course of CT-detected pulmonary ground-glass nodules in Chinese women with breast cancer: a retrospective, single-center, long-term follow-up study in 4682 consecutive patients

  2020cites this paper
• GATA-binding protein 3 and androgen receptor expressions in invasive breast cancer: the relationship with molecular phenotypes, disease progression, and survival outcomes

  2019cites this paper
• Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.

  2019cites this paper
• Breast metastasis from a pulmonary adenocarcinoma: Case report and review of the literature

  2019cites this paper
• ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes

  2019cites this paper
• Evaluation of the value of GATA 3 combined with E-cadherin in the diagnosis of breast cancer

  2019cites this paper
• Precision Medicine

  2019cites this paper
• The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer.

  2018cites this paper
• Markers and Immunoprofile of Breast Tumors

  2018cites this paper
• Breast metastasis from EGFR‐mutated lung adenocarcinoma: A case report and review of the literature

  2018cites this paper
• GATA3 as a putative marker of breast cancer metastasis—A retrospective immunohistochemical study

  2018cites this paper
• Comparative oncology research in Australia: establishing the Australian Veterinary Cancer Biobank to validate canine mammary tumours as a model for human breast cancer

  2018cites this paper
• Comparative analysis of the utility of GATA-binding protein 3 opposed to gross cystic disease fluid protein-15 in the diagnosis of metastatic breast carcinomas and diverse molecular subtypes

  2018cites this paper
• Metastatic non-small cell lung carcinoma a mimic of primary breast carcinoma—case series and literature review

  2018cites this paper
• Gata3 Immunohistochemical Staining is A Useful Marker for Metastatic Breast Carcinoma in Fine Needle Aspiration Specimens

  2018influential citation
• GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer

  2018cites this paper
• Malignant mesothelioma with squamous differentiation

  2018cites this paper
• A practical diagnostic approach to hepatic masses

  2018cites this paper
• Immunohistoochemical evaluation of GATA-3, pAKT and Ki-67 in triple negative breast carcinoma

  2017cites this paper
• Primary Small Cell Carcinoma Of Lung With Metachronous Breast Metastasis

  2017cites this paper
• Immunohistochemistry, carcinomas of unknown primary, and incidence rates.

  2017cites this paper
• Immunohistochemical Markers in Endometrial Carcinoma

  2017cites this paper
• GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung

  2017cites this paper
• GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.

  2017cites this paper
• Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.

  2017cites this paper
• How to Diagnose and Treat a Cancer of Unknown Primary Site.

  2017cites this paper
• Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells

  2017cites this paper
• Solitary breast metastasis from oestrogen receptor-positive pulmonary adenocarcinoma: report of a case with a potential pitfall.

  2017cites this paper
• Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes

  2017cites this paper
• Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural Neoplasms.

  2017cites this paper
• Targeted sequencing may facilitate differential diagnostics of pulmonary tumours: a case series

  2017cites this paper
• GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas.

  2017cites this paper
• Utility of TTF‐1 and Napsin‐A in the work‐up of malignant effusions

  2016cites this paper
• Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non–Small Cell Lung Carcinoma

  2016cites this paper
• Comparative Sensitivities and Specificities of Antibodies to Breast Markers GCDFP-15, Mammaglobin A, and Different Clones of Antibodies to GATA-3: A Study of 338 Tumors Using Whole Sections

  2016cites this paper
• The role of GATA3 in breast carcinomas: a review.

  2016influential citation
• The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs

  2016cites this paper
• Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma

  2016cites this paper
• Markers of metastatic carcinoma of breast origin

  2016cites this paper
• New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.

  2016cites this paper
• Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple‐negative tumours

  2016cites this paper
• Aberrant Expression of Napsin A in Breast Carcinoma With Apocrine Features

  2016cites this paper
• Breast metastasis from lung cancer : report of two cases of adenocarcinoma with different gene mutation and one case of squamous cell carcinoma

  2016cites this paper
• Immunohistochemistry markers in diagnosing high-grade serous carcinoma of ovary with breast metastasis: a rare case report

  2016cites this paper
• Recent advances in the pathology and molecular genetics of lung cancer: A practical review for cytopathologists.

  2016cites this paper
• Triple-Negative/Basal-Like Breast Carcinomas

  2016cites this paper
• Differentiating mammary carcinoma from ovarian and endometrial carcinoma using GATA3, MAM, and PAX8 expression: validations and limitations

  2016influential citation
• Close Relation of Large Cell Carcinoma to Adenocarcinoma by Hierarchical Cluster Analysis: Implications for Histologic Typing of Lung Cancer on Biopsies

  2015cites this paper
• Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.

  2015cites this paper
• Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung

  2015cites this paper
• GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.

  2015cites this paper
• Exfoliative Cytology and Effusions

  2015cites this paper
• Ancillary Immunohistochemical Techniques for the Subclassification of Non-small Cell Lung Cancer

  2015cites this paper
• Non small cell carcinoma of lung with metachronous breast metastasis and cardiac tamponade: Unusual presentation of a common cancer.

  2015cites this paper
• Metastatic Carcinoma of Unknown Primary: Diagnostic Approach Using Immunohistochemistry

  2015cites this paper
• Utility of GATA3, mammaglobin, GCDFP-15, and ER in the detection of intrathoracic metastatic breast carcinoma.

  2015cites this paper
• An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma*

  2015cites this paper